Predicting and Evaluating Anal Cancer in HIV with novel biomarkers: The PEACH Study

使用新型生物标志物预测和评估 HIV 患者肛门癌：PEACH 研究

• 批准号: 419916
• 负责人: Grennan Jonathan (Troy)
• 金额: $ 66.88万
• 依托单位: B.C. Centre for Disease Control (Vancouver)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-03-01 至 2024-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=419916&lang=en
• 关键词: Anal Cancer; Anal Cancer Screening; Biomarkers; Clinical Epidemiology; Diagnostic Tests; Human Immunodeficiency Virus (Hiv); Human Papillomavirus (Hpv); Men Who Have Sex With Men (Msm); Sexually Transmitted Infections (Stis)

Though there have been many improvements in the health of those living with HIV since the mid 1990s when effective therapies first emerged including reductions in AIDS-associated cancers, there have been increases in other types of cancer since that time.

虽然自20世纪90年代中期首次出现有效疗法以来，艾滋病毒感染者的健康状况有了许多改善，包括艾滋病相关癌症的减少，但自那时以来，其他类型的癌症有所增加。